Differential Regulation of MAPK Phosphorylation in the Dorsal Hippocampus in Response to Prolonged Morphine Withdrawal-Induced Depressive-Like Symptoms in Mice

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Jia, Wei ^a   Liu, Rui ^b   Shi, Jianguo ^a   Wu, Bin ^a   Dang, Wei ^a   Du, Ying ^b   Zhou, Qiong ^b   Wang, Jianhua ^b   Zhang, Rui ^a  

^a SHANDONG MENTAL HEALTH CENTER   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; MORPHINE; PROTEIN C JUN; SANGUINARINE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; DRUG DOSE ESCALATION; HIPPOCAMPUS; MALE; MOLECULAR MECHANICS; MORPHINE WITHDRAWAL INDUCED DEPRESSIVE LIKE SYMPTOM; MOUSE; NONHUMAN; OPEN FIELD TEST; PROTEIN PHOSPHORYLATION; SOCIAL INTERACTION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; WITHDRAWAL SYNDROME;

MUS;

ANIMALS; DEPRESSION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHINE; PHOSPHORYLATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84879169130     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066111     Document Type: Article

References (48)

1. Leshner AI, (1997) Addiction is a brain disease, and it matters. Science 278: 45-47.
2. Frenois F, Cador M, Caille S, Stinus L, Le Moine C, (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16: 1377-1389.
3. Nunes EV, Rounsaville BJ, (2006) Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction 101: 89-96.
4. Yu H, Chen ZY, (2011) The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin 32: 3-11.
5. Berke JD, Eichenbaum HB, (2001) Drug addiction and the hippocampus. Science 294: 1235.
6. Canales JJ, (2007) Adult neurogenesis and the memories of drug addiction. Eur Arch Psychiatry Clin Neurosci 257: 261-270.
7. Shu SY, Wu YM, Bao XM, Leonard B, (2003) Interactions among memory-related centers in the brain. J Neurosci Res 71: 609-616.
8. Carroll BJ (2004) Untreated depression and hippocampal volume loss. Am J Psychiatry 161: 1309-1310; author reply 1310-1301.
9. Sheline YI, Wang PW, Gado MH, Csernansky JG, Vannier MW, (1996) Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A 93: 3908-3913.
10. Stockmeier CA, Mahajan GJ, Konick LC, Overholser JC, Jurjus GJ, et al. (2004) Cellular changes in the postmortem hippocampus in major depression. Biol Psychiatry 56: 640-650.
11. Schmidt HD, Duman RS, (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18: 391-418.
12. Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, et al. (2000) Serine/threonine protein kinases and apoptosis. Exp Cell Res 256: 34-41.
13. Grewal SS, York RD, Stork PJ, (1999) Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol 9: 544-553.
14. Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, et al. (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22: 153-183.
15. Bokemeyer D, Sorokin A, Yan MH, Ahn NG, Templeton DJ, et al. (1996) Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J Biol Chem 271: 639-642.
16. Brondello JM, Brunet A, Pouyssegur J, McKenzie FR, (1997) The dual specificity mitogen-activated protein kinase phosphatase-1 and-2 are induced by the p42/p44(MAPK) cascade. J Biol Chem 272: 1368-1376.
17. Muda M, Boschert U, Dickinson R, Martinou JC, Martinou I, et al. (1996) MKP-3, a novel cytosolic protein-tyrosine phosphatase that exemplifies a new class of mitogen-activated protein kinase phosphatase. J Biol Chem 271: 4319-4326.
18. Liu Q, Wang X, Liu Y, Lu R, Yuan Q, et al. (2011) RACK1 inhibits morphine re-exposure via inhibition of Src. Neurol Res 33: 56-62.
19. Ligeza A, Wawrzczak-Bargiela A, Kaminska D, Korostynski M, Przewlocki R, (2008) Regulation of ERK1/2 phosphorylation by acute and chronic morphine- implications for the role of cAMP-responsive element binding factor (CREB)-dependent and Ets-like protein-1 (Elk-1)-dependent transcription; small interfering RNA-based strategy. FEBS J 275: 3836-3849.
20. Sun WL, Zhou L, Hazim R, Quinones-Jenab V, Jenab S, (2008) Effects of dopamine and NMDA receptors on cocaine-induced Fos expression in the striatum of Fischer rats. Brain Res 1243: 1-9.
21. Takaki M, Ujike H, Kodama M, Takehisa Y, Nakata K, et al. (2001) Two kinds of mitogen-activated protein kinase phosphatases, MKP-1 and MKP-3, are differentially activated by acute and chronic methamphetamine treatment in the rat brain. J Neurochem 79: 679-688.
22. Duric V, Banasr M, Licznerski P, Schmidt HD, Stockmeier CA, et al. (2010) A negative regulator of MAP kinase causes depressive behavior. Nat Med 16: 1328-1332.
23. Heinzen EL, Pollack GM, (2004) Pharmacodynamics of morphine-induced neuronal nitric oxide production and antinociceptive tolerance development. Brain Res 1023: 175-184.
24. Rehni AK, Singh N, (2011) Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice. Behav Pharmacol 22: 182-190.
25. Le Duigou C, Wittner L, Danglot L, Miles R, (2005) Effects of focal injection of kainic acid into the mouse hippocampus in vitro and ex vivo. J Physiol 569: 833-847.
26. George Paxinos KBJF (2001) The Mouse Brain in Stereotaxic Coordinates. 2nd ed. ed. San Diego, California 92101-4495, USA: Academic Press.
27. Chen Y, Wang H, Zhang R, Wang H, Peng Z, et al. (2012) Microinjection of sanguinarine into the ventrolateral orbital cortex inhibits Mkp-1 and exerts an antidepressant-like effect in rats. Neurosci Lett 506: 327-331.
28. Miyakawa T, Leiter LM, Gerber DJ, Gainetdinov RR, Sotnikova TD, et al. (2003) Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc Natl Acad Sci U S A 100: 8987-8992.
29. Zhang L, Lou D, Jiao H, Zhang D, Wang X, et al. (2004) Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci 24: 3344-3354.
30. Haghparast A, Taslimi Z, Ramin M, Azizi P, Khodagholi F, et al. (2011) Changes in phosphorylation of CREB, ERK, and c-fos induction in rat ventral tegmental area, hippocampus and prefrontal cortex after conditioned place preference induced by chemical stimulation of lateral hypothalamus. Behav Brain Res 220: 112-118.
31. Rehni AK, Singh TG (2013) Pharmacological modulation of geranylgeranyltransferase and farnesyltransferase attenuates opioid withdrawal in vivo and in vitro. Neuropharmacology.
32. Goeldner C, Lutz PE, Darcq E, Halter T, Clesse D, et al. (2011) Impaired emotional-like behavior and serotonergic function during protracted abstinence from chronic morphine. Biol Psychiatry 69: 236-244.
33. Koob GF, Maldonado R, Stinus L, (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15: 186-191.
34. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, et al. (1999) Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290: 881-892.
35. Bechara A, Nader K, van der Kooy D, (1995) Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal. Behav Neurosci 109: 91-105.
36. Yu T, Guo M, Garza J, Rendon S, Sun XL, et al. (2011) Cognitive and neural correlates of depression-like behaviour in socially defeated mice: an animal model of depression with cognitive dysfunction. Int J Neuropsychopharmacol 14: 303-317.
37. Kim SJ, Lee H, Lee G, Oh SJ, Shin MK, et al. (2012) CD4(+)CD25(+) Regulatory T Cell Depletion Modulates Anxiety and Depression-Like Behaviors in Mice. PLoS One 7: e42054.
38. Prut L, Belzung C, (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463: 3-33.
39. Zimmerman M, McDermut W, Mattia JI, (2000) Frequency of anxiety disorders in psychiatric outpatients with major depressive disorder. Am J Psychiatry 157: 1337-1340.
40. Hafen E, (1998) Kinases and phosphatases- A marriage is consummated. Science 280: 1212-1213.
41. Muda M, Theodosiou A, Rodrigues N, Boschert U, Camps M, et al. (1996) The dual specificity phosphatases M3/6 and MKP-3 are highly selective for inactivation of distinct mitogen-activated protein kinases. J Biol Chem 271: 27205-27208.
42. Qi X, Lin W, Li J, Pan Y, Wang W, (2006) The depressive-like behaviors are correlated with decreased phosphorylation of mitogen-activated protein kinases in rat brain following chronic forced swim stress. Behav Brain Res 175: 233-240.
43. Dwivedi Y, Mondal AC, Rizavi HS, Conley RR, (2005) Suicide brain is associated with decreased expression of neurotrophins. Biol Psychiatry 58: 315-324.
44. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, et al. (2001) Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 77: 916-928.
45. Vogt A, Tamewitz A, Skoko J, Sikorski RP, Giuliano KA, et al. (2005) The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem 280: 19078-19086.
46. Li T, Hou Y, Cao W, Yan CX, Chen T, et al. (2010) Naloxone-precipitated withdrawal enhances ERK phosphorylation in prefrontal association cortex and accumbens nucleus of morphine-dependent mice. Neurosci Lett 468: 348-352.
47. Qi X, Lin W, Wang D, Pan Y, Wang W, et al. (2009) A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 199: 203-209.
48. Fukunaga K, Miyamoto E, (1998) Role of MAP kinase in neurons. Mol Neurobiol 16: 79-95.